Tech Company Financing Transactions
Molecular Partners Funding Round
On 12/15/2009, Molecular Partners landed $45 million in Series B funding from EW Healthcare Partners, BB Biotech Ventures and Index Ventures.
Transaction Overview
Company Name
Announced On
12/15/2009
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors
EW Healthcare Partners (Lead Investor) (Petri Vainio)
Index Ventures (Francesco Rubertis)
Proceeds Purpose
The new funds will enable Molecular Partners not only to advance its lead compound MP0112, a best-in-class VEGF antagonist, into clinical proof of concept studies in two indications in ophthalmology, but will also support the development of Molecular Partners' broad proprietary pipeline of preclinical DARPin candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Wagistrasse 14
Zürich-Schlieren, 8952
Switzerland
Zürich-Schlieren, 8952
Switzerland
Phone
Website
Email Address
Overview
Molecular Partners is a privately held biotech company focusing on the commercialization of a novel class of biological drugs known as DARPins. The company is using/exploiting this novel class of protein therapeutics to create medicines for diseases with unmet medical need and to dramatically improve existing therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Amstutz
Chief Financial Officer
Andreas Emmenegger
Chief Operating Officer
Michael Stumpp
VP - Finance
Robert Hendriks
VP - General Counsel
Julien Gander
VP - Human Resources
Thomas Schwerzmann
Browse more venture capital transactions:
Prev: 12/15/2009: ExaGrid Systems venture capital transaction
Next: 12/15/2009: Nasuni venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs